Albano L et al. |
OSAKA trial: a randomized, controlled trial comparing tacrolimus QD and BD in kidney transplantation. |
2013 |
Transplantation |
pmid:23982340
|
Troppmann C et al. |
Higher surgical wound complication rates with sirolimus immunosuppression after kidney transplantation: a matched-pair pilot study. |
2003 |
Transplantation |
pmid:12883205
|
Therapondos G et al. |
Cardiac hypertrophy in liver transplant recipients: tacrolimus, cyclosporine or both? |
2003 |
Transplantation |
pmid:12883220
|
Marcos A et al. |
Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: with particular reference to hepatitis C virus. |
2004 |
Transplantation |
pmid:15480160
|
Heeckt PF et al. |
Functional impairment of enteric smooth muscle and nerves caused by chronic intestinal allograft rejection regresses after FK506 rescue. |
1995 |
Transplantation |
pmid:7530870
|
Gruessner RW et al. |
A prospective study of FK506 versus CsA and pig ATG in a porcine model of small bowel transplantation. |
1995 |
Transplantation |
pmid:7530871
|
Jindal RM et al. |
Serum lipid changes in liver transplant recipients in a prospective trial of cyclosporine versus FK506. |
1994 |
Transplantation |
pmid:7514317
|
Boleslawski E et al. |
Defective inhibition of peripheral CD8+ T cell IL-2 production by anti-calcineurin drugs during acute liver allograft rejection. |
2004 |
Transplantation |
pmid:15223897
|
Wozniak LJ et al. |
Donor-specific HLA Antibodies Are Associated With Late Allograft Dysfunction After Pediatric Liver Transplantation. |
2015 |
Transplantation |
pmid:26038872
|
Kuypers DR et al. |
Maintenance immunosuppressive agents as risk factors for BK virus nephropathy: the need for true drug exposure measurements. |
2010 |
Transplantation |
pmid:20555228
|
Gaber AO et al. |
Acute rejection characteristics from a prospective, randomized, double-blind, placebo-controlled multicenter trial of early corticosteroid withdrawal. |
2013 |
Transplantation |
pmid:23423269
|
Guethoff S et al. |
Ten-year results of a randomized trial comparing tacrolimus versus cyclosporine a in combination with mycophenolate mofetil after heart transplantation. |
2013 |
Transplantation |
pmid:23423270
|
Bilolo KK et al. |
Synergistic effects of malononitrilamides (FK778, FK779) with tacrolimus (FK506) in prevention of acute heart and kidney allograft rejection and reversal of ongoing heart allograft rejection in the rat. |
2003 |
Transplantation |
pmid:12811249
|
Miyakoshi S et al. |
Tacrolimus as prophylaxis for acute graft-versus-host disease in reduced intensity cord blood transplantation for adult patients with advanced hematologic diseases. |
2007 |
Transplantation |
pmid:17700155
|
Huang E et al. |
Alemtuzumab induction in deceased donor kidney transplantation. |
2007 |
Transplantation |
pmid:17984833
|
Kato T et al. |
Randomized trial of steroid-free induction versus corticosteroid maintenance among orthotopic liver transplant recipients with hepatitis C virus: impact on hepatic fibrosis progression at one year. |
2007 |
Transplantation |
pmid:17984834
|
Jain A et al. |
Delayed introduction of tacrolimus postliver transplant with intravenous mycophenolate mofetil preserves renal function without incurring rejection. |
2014 |
Transplantation |
pmid:25285953
|
Eiras G et al. |
Species differences in sensitivity of T lymphocytes to immunosuppressive effects of FK 506. |
1990 |
Transplantation |
pmid:1694318
|
Tze WJ et al. |
In vitro effects of FK-506 on human and rat islets. |
1990 |
Transplantation |
pmid:1694319
|
Valdivia LA et al. |
Successful hamster-to-rat liver xenotransplantation under FK506 immunosuppression induces unresponsiveness to hamster heart and skin. |
1993 |
Transplantation |
pmid:7681230
|
Shapiro R et al. |
A prospective randomized trial of FK506-based immunosuppression after renal transplantation. |
1995 |
Transplantation |
pmid:7533343
|
Cox KL et al. |
An increased incidence of Epstein-Barr virus infection and lymphoproliferative disorder in young children on FK506 after liver transplantation. |
1995 |
Transplantation |
pmid:7533344
|
Sakr M et al. |
The protective effect of FK506 pretreatment against renal ischemia/reperfusion injury in rats. |
1992 |
Transplantation |
pmid:1374948
|
Yanchar NL et al. |
Tacrolimus (FK506)--its effects on intestinal glucose transport. |
1996 |
Transplantation |
pmid:8610392
|
Solez K et al. |
Histopathologic findings from 2-year protocol biopsies from a U.S. multicenter kidney transplant trial comparing tarolimus versus cyclosporine: a report of the FK506 Kidney Transplant Study Group. |
1998 |
Transplantation |
pmid:9884269
|
Reyes J et al. |
Expressive dysphasia possibly related to FK506 in two liver transplant recipients. |
1990 |
Transplantation |
pmid:1701571
|
Egidi MF and Gaber AO |
Outcomes of African-American kidney-transplant recipients treated with sirolimus, tacrolimus, and corticosteroids. |
2003 |
Transplantation |
pmid:12605133
|
Ciancio G et al. |
Randomized trial of mycophenolate mofetil versus enteric-coated mycophenolate sodium in primary renal transplantation with tacrolimus and steroid avoidance: four-year analysis. |
2011 |
Transplantation |
pmid:21107305
|
Squifflet JP et al. |
Dose optimization of mycophenolate mofetil when administered with a low dose of tacrolimus in cadaveric renal transplant recipients. |
2001 |
Transplantation |
pmid:11468536
|
Theruvath TP et al. |
Control of antidonor antibody production with tacrolimus and mycophenolate mofetil in renal allograft recipients with chronic rejection. |
2001 |
Transplantation |
pmid:11468538
|
Kung L and Halloran PF |
Immunophilins may limit calcineurin inhibition by cyclosporine and tacrolimus at high drug concentrations. |
2000 |
Transplantation |
pmid:10933159
|
Beatty PR et al. |
Effect of cyclosporine and tacrolimus on the growth of Epstein-Barr virus-transformed B-cell lines. |
1998 |
Transplantation |
pmid:9603175
|
Arzouk N et al. |
Interaction between tacrolimus and fumagillin in two kidney transplant recipients. |
2006 |
Transplantation |
pmid:16421493
|
Zervos XA et al. |
Comparison of tacrolimus with microemulsion cyclosporine as primary immunosuppression in hepatitis C patients after liver transplantation. |
1998 |
Transplantation |
pmid:9583863
|
Maes BD et al. |
Differences in gastric motor activity in renal transplant recipients treated with FK-506 versus cyclosporine. |
1999 |
Transplantation |
pmid:10589943
|
Mehra MR et al. |
Ethnic disparity in clinical outcome after heart transplantation is abrogated using tacrolimus and mycophenolate mofetil-based immunosuppression. |
2002 |
Transplantation |
pmid:12490790
|
First MR et al. |
New-onset diabetes after transplantation (NODAT): an evaluation of definitions in clinical trials. |
2013 |
Transplantation |
pmid:23619735
|
Andries S et al. |
Posttransplant immune hepatitis in pediatric liver transplant recipients: incidence and maintenance therapy with azathioprine. |
2001 |
Transplantation |
pmid:11477351
|
Woodle ES et al. |
FK506: inhibition of humoral mechanisms of hepatic allograft rejection. |
1992 |
Transplantation |
pmid:1379749
|
Taler SJ et al. |
Role of steroid dose in hypertension early after liver transplantation with tacrolimus (FK506) and cyclosporine. |
1996 |
Transplantation |
pmid:8970613
|
Naesens M et al. |
Maturation of dose-corrected tacrolimus predose trough levels in pediatric kidney allograft recipients. |
2008 |
Transplantation |
pmid:18431234
|
Dean PG et al. |
Kidney transplant histology after one year of continuous therapy with sirolimus compared with tacrolimus. |
2008 |
Transplantation |
pmid:18431244
|
Shoji T et al. |
Operational tolerance to class I disparate lungs can be induced despite pretransplant immunization with class I allopeptides. |
2007 |
Transplantation |
pmid:18091523
|
Cantarovich D et al. |
Switching from cyclosporine to tacrolimus in patients with chronic transplant dysfunction or cyclosporine-induced adverse events. |
2005 |
Transplantation |
pmid:15714172
|
Nguyen L et al. |
Conversion from tacrolimus/mycophenolic acid to tacrolimus/leflunomide to treat cutaneous warts in a series of four pediatric renal allograft recipients. |
2012 |
Transplantation |
pmid:22960763
|
Thomas PG et al. |
Alemtuzumab (Campath 1H) induction with tacrolimus monotherapy is safe for high immunological risk renal transplantation. |
2007 |
Transplantation |
pmid:17565326
|
Shapiro R et al. |
Tacrolimus in pediatric renal transplantation. |
1996 |
Transplantation |
pmid:8990356
|
Przepiorka D et al. |
Allogeneic transplantation for advanced leukemia: improved short-term outcome with blood stem cell grafts and tacrolimus. |
1996 |
Transplantation |
pmid:8990368
|
Wissing KM et al. |
Effect of atorvastatin therapy and conversion to tacrolimus on hypercholesterolemia and endothelial dysfunction after renal transplantation. |
2006 |
Transplantation |
pmid:17006324
|
Foster RD et al. |
Long-term acceptance of composite tissue allografts through mixed chimerism and CD28 blockade. |
2003 |
Transplantation |
pmid:14508367
|